Yaron Werber
Stock Analyst at TD Cowen
(1.04)
# 3,617
Out of 4,761 analysts
41
Total ratings
35.71%
Success rate
-18.27%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yaron Werber
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FBRX Forte Biosciences | Initiates: Buy | n/a | $10.98 | - | 1 | Jan 21, 2025 | |
| DNTH Dianthus Therapeutics | Initiates: Buy | n/a | $23.67 | - | 1 | Dec 20, 2024 | |
| SEPN Septerna | Initiates: Buy | n/a | $5.80 | - | 1 | Nov 19, 2024 | |
| ASND Ascendis Pharma | Maintains: Buy | $160 → $153 | $152.43 | +0.37% | 5 | Nov 15, 2024 | |
| BNTX BioNTech SE | Maintains: Hold | $132 → $122 | $120.01 | +1.66% | 5 | Nov 6, 2024 | |
| UPB Upstream Bio | Initiates: Buy | n/a | $7.98 | - | 1 | Nov 5, 2024 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $61 → $73 | $42.59 | +71.40% | 2 | Oct 21, 2024 | |
| EXEL Exelixis | Maintains: Buy | $27 → $34 | $36.85 | -7.73% | 2 | Oct 21, 2024 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $54 → $59 | $32.32 | +82.55% | 1 | Jul 23, 2024 | |
| LEGN Legend Biotech | Maintains: Buy | $71 → $67 | $39.70 | +68.77% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $8.33 | - | 1 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $5.96 | - | 1 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $1.76 | - | 2 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $2.61 | - | 2 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $22.46 | - | 1 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $612 → $641 | $644.48 | -0.54% | 3 | Dec 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $0.61 | - | 1 | Oct 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $15 → $25 | $0.71 | +3,441.58% | 1 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $22.12 | - | 2 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $38 | $22.34 | +70.10% | 1 | May 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $4.08 | - | 3 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.10 | - | 1 | Nov 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $10.68 | - | 1 | Oct 26, 2021 |
Forte Biosciences
Jan 21, 2025
Initiates: Buy
Price Target: n/a
Current: $10.98
Upside: -
Dianthus Therapeutics
Dec 20, 2024
Initiates: Buy
Price Target: n/a
Current: $23.67
Upside: -
Septerna
Nov 19, 2024
Initiates: Buy
Price Target: n/a
Current: $5.80
Upside: -
Ascendis Pharma
Nov 15, 2024
Maintains: Buy
Price Target: $160 → $153
Current: $152.43
Upside: +0.37%
BioNTech SE
Nov 6, 2024
Maintains: Hold
Price Target: $132 → $122
Current: $120.01
Upside: +1.66%
Upstream Bio
Nov 5, 2024
Initiates: Buy
Price Target: n/a
Current: $7.98
Upside: -
Ultragenyx Pharmaceutical
Oct 21, 2024
Maintains: Buy
Price Target: $61 → $73
Current: $42.59
Upside: +71.40%
Exelixis
Oct 21, 2024
Maintains: Buy
Price Target: $27 → $34
Current: $36.85
Upside: -7.73%
Ionis Pharmaceuticals
Jul 23, 2024
Maintains: Buy
Price Target: $54 → $59
Current: $32.32
Upside: +82.55%
Legend Biotech
Jul 15, 2024
Maintains: Buy
Price Target: $71 → $67
Current: $39.70
Upside: +68.77%
Mar 26, 2024
Upgrades: Buy
Price Target: n/a
Current: $8.33
Upside: -
Mar 18, 2024
Initiates: Outperform
Price Target: n/a
Current: $5.96
Upside: -
Mar 15, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $1.76
Upside: -
Jan 31, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $2.61
Upside: -
Dec 20, 2023
Initiates: Outperform
Price Target: n/a
Current: $22.46
Upside: -
Dec 12, 2023
Maintains: Outperform
Price Target: $612 → $641
Current: $644.48
Upside: -0.54%
Oct 19, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $0.61
Upside: -
Feb 28, 2023
Maintains: Market Perform
Price Target: $15 → $25
Current: $0.71
Upside: +3,441.58%
Nov 1, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $22.12
Upside: -
May 2, 2022
Initiates: Market Perform
Price Target: $38
Current: $22.34
Upside: +70.10%
Apr 6, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $4.08
Upside: -
Nov 30, 2021
Initiates: Outperform
Price Target: n/a
Current: $1.10
Upside: -
Oct 26, 2021
Initiates: Outperform
Price Target: n/a
Current: $10.68
Upside: -